Bendroflumethiazide

국가: 뉴질랜드

언어: 영어

출처: Medsafe (Medicines Safety Authority)

유효 성분:

Bendroflumethiazide 2.5mg;  ;  

제공처:

Ipca Pharma (NZ) Pty Limited

INN (International Name):

Bendroflumethiazide 2.5 mg

복용량:

2.5 mg

약제 형태:

Tablet

구성:

Active: Bendroflumethiazide 2.5mg     Excipient: Lactose Purified talc Starch Stearic acid

패키지 단위:

Blister pack, PVC/PVDC, 14 tablets

수업:

Prescription

처방전 유형:

Prescription

Manufactured by:

Ipca Laboratories Limited

치료 징후:

Bendrofluazide is indicated in the treatment of oedema associated with conditions such as: congestive heart failure, nephrotic syndrome and cirrhosis of the liver.

제품 요약:

Package - Contents - Shelf Life: Blister pack, PVC/PVDC - 14 tablets - 24 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC - 28 tablets - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE - 500 tablets - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE - 1000 tablets - 24 months from date of manufacture stored at or below 25°C

승인 날짜:

2006-06-28